Page last updated: 2024-10-25

clotrimazole and Injuries, Radiation

clotrimazole has been researched along with Injuries, Radiation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Sayed, S2
Nabid, A1
Shelley, W1
Hay, J2
Balogh, J1
Gelinas, M1
MacKenzie, R1
Read, N1
Berthelet, E1
Lau, H1
Epstein, J2
Delvecchio, P1
Ganguly, PK1
Wong, F1
Burns, P2
Tu, D1
Pater, J1
Minish, E1
Laukkanen, E1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Randomized Evaluation of a Phytopharmaceutical in Prevention of Severe Oral Mucositis in Patients Receiving Radiotherapy for Oral Cavity, Oropharynx, Hypopharynx, or Cavum Cancer[NCT01066741]Phase 378 participants (Actual)Interventional2009-05-31Terminated (stopped due to insufficient recruitment, the planed sample size appears not achievable)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for clotrimazole and Injuries, Radiation

ArticleYear
Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis sc
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Oct-01, Volume: 20, Issue:19

    Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacitracin; Clotrimazole;

2002
A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy.
    Head & neck, 2002, Volume: 24, Issue:1

    Topics: Administration, Oral; Adult; Aged; Bacitracin; Carcinoma, Squamous Cell; Clotrimazole; Female; Follo

2002